Sanofi (SNY) Tops Q4 EPS by 79c

Sanofi (NASDAQ: SNY) reported Q4 EPS of EUR1.71, EUR0.79 better than the analyst estimate of EUR0.92. Revenue for the quarter came in at EUR10.72 billion versus the consensus estimate of EUR12.2 billion.

For earnings history and earnings-related data on Sanofi (SNY) click here.

You May Also Be Interested In

• UBS sees a negative catalyst ahead for Nike: Here’s what to watch
• RBC bullish on Kraft Heinz, sees return to growth in 2027
• Wall Street on Fed rate hike: 'As hawkish as it gets'